Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Molecular Breast Imaging in Patients With a High Likelihood of Ductal Carcinoma in Situ

NCT00890994 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00890994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Molecular Breast Imaging in Patients With a High Likelihood of Ductal Carcinoma in Situ
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
January 19, 2009
Completion date
November 14, 2016
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer